What's happening
This bill prohibits health plans from changing prescription drug formularies during a plan year, with limited exceptions and required advance notice.
Why it matters
Stability for Patients. By locking in prescription drug formularies for an entire plan year, patients with chronic or ongoing health needs can better anticipate and budget for their medication expenses, reducing the risk of sudden, unaffordable price hikes or loss of coverage for necessary drugs.
Transparency and Consumer Choice. The advance notice requirement (at least 30 days before open enrollment) gives consumers time to review any upcoming changes and make informed decisions about whether to keep or switch health plans based on their medication needs.
Limits on Exceptions. The bill allows for certain exceptions—such as when a safer or more cost-effective generic or biosimilar is introduced, or when the FDA pulls a drug for safety reasons—but restricts these changes to avoid harming current users or those with specific medical needs, thus balancing cost management with patient protection.
Protects Bargained Benefits. The legislation explicitly does not override collective bargaining agreements, meaning unionized workers and their representatives retain the right to negotiate drug coverage terms, preserving their leverage and tailored benefits.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Stop Midyear Drug Changes
Plain English, a few words. Used as the page title.
Sponsors
32 Co-sponsors
- Joseph P. Addabbo Jr.
- Brian Benjamin
- Alessandra Biaggi
- John E. Brooks
- Leroy Comrie
- Jim Gaughran
- Michael Gianaris
- Joseph A. Griffo
- Pamela Helming
- Michelle Hinchey
- Brad Hoylman-Sigal
- Daphne Jordan
- Todd Kaminsky
- Anna Kaplan
- Timothy M. Kennedy
- Liz Krueger
- Andrew J. Lanza
- John Mannion
- Rachel May
- Shelley Mayer
- Zellnor Myrie
- Kevin S. Parker
- Patty Ritchie
- Gustavo Rivera
- Julia Salazar
- James Sanders Jr.
- Diane J. Savino
- Luis R. Sepúlveda
- Susan Serino
- José M. Serrano
- James Skoufis
- Kevin Thomas
History
- Approval memo.136
- Signed chap.780
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading cal.361
- Substituted for A4668
- Referred to insurance
- Delivered to assembly
- Passed senateVote 53–9
- Advanced to third reading
- 2nd report cal.
Show 2 earlier actions
- 1st report cal.574
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Stop Midyear Drug Changes
Assembly Floor Calendar · Sponsor Crystal Peoples-Stokes
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4111
2021-2022 Regular Sessions
IN SENATE
February 2, 2021
Introduced by Sens. BRESLIN, ADDABBO, BENJAMIN, BIAGGI, BROOKS, COMRIE, GAUGHRAN, GIANARIS, GRIFFO, HELMING, HOYLMAN, JORDAN, KAMINSKY, KAPLAN, KENNEDY, KRUEGER, LANZA, MAY, MAYER, MYRIE, PARKER, RITCHIE, RIVERA, SALAZAR, SANDERS, SAVINO, SEPULVEDA, SERINO, SERRANO, SKOUFIS, THOMAS -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The insurance law is amended by adding a new section 4909 to read as follows:
§ 4909. Prescription drug formulary changes. (a) Except as otherwise provided in subsection (c) of this section, a health care plan shall not:
(i) remove a prescription drug from a formulary;
(ii) move a prescription drug to a tier with a larger deductible, copayment, or coinsurance if the formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier; or
(iii) add utilization management restrictions to a prescription drug on a formulary, unless such changes occur at the time of enrollment or issuance of coverage.
(b) Prohibitions provided in subsection (a) of this section shall apply beginning on the date on which open enrollment begins for a plan year and through the end of the plan year to which such open enrollment period applies.
(c) (i) A health care plan with a formulary that includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to prescription drugs in each tier may move a prescription drug to a tier with a larger deductible, copayment or coin-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08236-01-1
S. 4111 2
surance if an AB-rated generic equivalent or interchangeable biological product for such prescription drug is added to the formulary at the same time.
(ii) A health care plan may remove a prescription drug from a formulary if the federal Food and Drug Administration determines that such prescription drug should be removed from the market, including new utilization management restrictions issued pursuant to federal Food and Drug Administration safety concerns.
(iii) A health care plan with a formulary that includes two or more tiers of benefits providing for different copayments applicable to prescription drugs may move a prescription drug to a tier with a larger copayment during the plan year, provided the change is not applicable to an insured who is already receiving such prescription drug or has been diagnosed with or presented with a condition on or prior to the start of the plan year which is treated by such prescription drug or is a prescription drug that is or would be part of the insured's treatment regimen for such condition.
(d) A health care plan shall provide notice to policyholders of the intent to remove a prescription drug from a formulary or alter deductible, copayment or coinsurance requirements in the upcoming plan year, thirty days prior to the open enrollment period for the consecutive plan year. Such notice of impending formulary and deductible, copayment or coinsurance changes shall also be posted on the plan's online formulary and in any prescription drug finder system that the plan provides to the public.
(e) The provisions of this section shall not supersede the terms of a collective bargaining agreement, or the rights of labor representation groups to collectively bargain changes to the formularies.
§ 2. The public health law is amended by adding a new section 4909 to read as follows:
§ 4909. Prescription drug formulary changes. 1. Except as otherwise provided in subdivision three of this section, a health care plan shall not:
(a) remove a prescription drug from a formulary;
(b) move a prescription drug to a tier with a larger deductible, copayment, or coinsurance if the formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier; or
(c) add utilization management restrictions to a prescription drug on a formulary, unless such changes occur at the time of enrollment or issuance of coverage.
2. Prohibitions provided in subdivision one of this section shall apply beginning on the date on which open enrollment begins for a plan year and through the end of the plan year to which such open enrollment period applies.
3. (a) A health care plan with a formulary that includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to prescription drugs in each tier may move a prescription drug to a tier with a larger deductible, copayment or coinsurance if an AB-rated generic equivalent or interchangeable biological product for such prescription drug is added to the formulary at the same time.
(b) A health care plan may remove a prescription drug from a formulary if the federal Food and Drug Administration determines that such prescription drug should be removed from the market, including new
S. 4111 3
utilization management restrictions issued pursuant to federal Food and Drug Administration safety concerns.
(c) A health care plan with a formulary that includes two or more tiers of benefits providing for different copayments applicable to prescription drugs may move a prescription drug to a tier with a larger copayment during the plan year, provided the change is not applicable to an insured who is already receiving such prescription drug or has been diagnosed with or presented with a condition on or prior to the start of the plan year which is treated by such prescription drug or is a prescription drug that is or would be part of the insured's treatment regimen for such condition.
4. A health care plan shall provide notice to policyholders of the intent to remove a prescription drug from a formulary or alter deductible, copayment or coinsurance requirements in the upcoming plan year, thirty days prior to the open enrollment period for the consecutive plan year. Such notice of impending formulary and deductible, copayment or coinsurance changes shall also be posted on the plan's online formulary and in any prescription drug finder system that the plan provides to the public.
5. The provisions of this section shall not supersede the terms of a collective bargaining agreement, or the rights of labor representation groups to collectively bargain changes to the formularies.
§ 3. This act shall take effect on the sixtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implantation of this act on its effective date are authorized to be made on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year
Purpose or general idea of bill
To clarify that health insurance consumers covered by plans that are required to offer essential health benefits under the affordable care act are protected from adverse effects of mid-year formulary charges, and properly notified. of formulary changes.
Summary of provisions
Section 1 adds a new section 4909 to the Insurance Law to state that a health care plan which provides essential health benefits under the federal affordable care act may not remove a prescription drug from a formulary during the enrollment. year. If the plan's drug formulary has two or more tiers of drug benefits with different deductibles, copay- ments or coinsurance, the plan may not move a drug to a tier with higher patient cost sharing during the enrollment year. The pie: may also not add new or additional formulary restrictions during the enrollment year. A health care plan ma:- move a prescription drug to a. tier with a long- er copayment, coinsurance and different deductible if an AB-rated gener- ic equivalent drug or interchangeable biological product is added to the formulary at the same tine. However, a health care plan with a formulary that is eludes two or more tiers of benefits providing for different copayments applicable to proscription drugs, may move a prescription drug to a different tier with a larger copayment, provided the change is not applicable to an insured who is already receiving such prescription drug or has been diagnosed with or presented with a condition on or prior to the start of the plan year which is treated by such prescription drug or is a drug part of their regimen.
Read the full memo (793 words)
In addition, provide notice to policyholders of the intent to remove a prescription drugs from a formulary or alter deductible, copayments coinsurance requirements in the upcoming plan year, thirty days prior to the open enrollment period for the consecutive plan year. This section also provides that terms of a Collective bargaining agreement shall not be superseded.
Section 2 adds a new section 4909 to the Public health law to also state that a health care plan whit provides essential health benefits under the federal affordable care act may not remove a prescription drug from a formulary during the enrollment year. If the plan's drug formulary has two or more tiers of drug benefits with different deductibles, copay- ments or coinsurance, the plait may not hove a drug to a tier with high- er patient cost sharing during the enrollment year. The plan may also or t add new or additional formulary restrictions during the enrollment year A health care plan may move a prescription drug to a tier with a larger copayment, coinsurance and different deductible if an AB-rated generic equivalent drug or interchangeable biological product is added to the formulary at the same time. in addition, provide notice to poli- cyholders of the intent to remove a prescription drugs from a formulary or alter deductible, copayment or coinsurance requirements in the upcom- ing plan year, thirty days prior to the open enrollment period for the consecutive plan year. This section also provides that terms of a collective bargaining agree-re-ant shall not be superseded.
Section 3 provides that th:Ha act would take effect on the 60th day after enactment, provided that effective immediately the superintendent of insurance may make regulations and take other actions necessary to implement the act.
Justification
This bill ensures that enrollees who select a health exchange plan based on their individual prescription dine needs have assurance that the health plan will maintain continuity in coverage for those prescription drugs during the course of the enrollment year, and be provided adequate notice of the intent to remove a prescription on the upcoming plan year. Enrollees choose health exchange plans based or the formulary status of a necessary therapy. A change in prescription drug availability could result in serious medical problems for the enrollee. Also, these unex- pected formulary changes can be extremely financially burdensome and have negative health outcomes.
Prior legislative history
2019-20: S.2649a Vetoed. 245
A. 2317-C of 2017/2018;
A.7707A of 2015/2016
2018: S. 3025c - Referred to Insurance
2016: S.5382a - Referred to Insurance
Fiscal implications for state and local governments
None.
Effective date
This act shall take effect on the sixtieth. day after it shall have become a law; provided, however, that effective immediately, the addi- tion, amendment. and/or repeal of any rule or regulation necessary for tie implementation of this act on its effective date are authorized to be made and completed by the superintendent of financial services on or before such date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.